FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of the formula (I) or their pharmaceutically acceptable salts that can be used for the treatment of bacterial infections. In the formula (I), R1 and R2 each independently is -(С1-С6)alkyl-OR23, -CH2CH(OH)CH2NH2, -CH2C(O)NH2 or -(C1-C6)alkyl-NR21R22; R6, R7 and R8 each independently is Н or -(С1-С6)alkyl; R9, R10 are Н or -(С1-С6)alkyl; R11 and R12 each independently is Н, -NH2, -(С1-С6)alkyl, -(C1-C6)alkyl-OR23, -(Cl-C6)alkyl-NR21R22, -(С1-С6)alkyl-CN, -(C1-C6)alkyl-C(O)NR25R26, -(C1-С6)alkyl-N(Н)СН=NH or -(C1-C6)alkyl-N(H)C(NH)NH2; R15, R16, R17 and R18 each independently is Н or -(С1-С6)alkyl; А is -CN, -CH2CN, -CH=CHCN, -CH2N(H)C(O)CH2CN, -CH2N(H)C(O)N(H)R24, -C(O)N(H)R34, -C(O)N(H)C(R23)2C(O)OR29, C(O)N(H)C(R23)2C(O)NR32R33, -C(O)N(H)C(R23)2C=NR30, etc., X is -(С1-С6)alkyl-, -(С2-С6)alkenyl-, -(С2-С6)alkynyl, -(С3-С7)cycloalkyl-, 3-20-element heterocycloalkyl containing 1-3 heteroatoms selected from N, О and S, optionally substituted 6-14-element aryl or optionally substituted 5-12-element heteroaryl containing 1-3 heteroatoms selected from N, О and S; Y is a bound, -(С1-С6)alkyl-, -(С2-С6)alkenyl-, -(С2-С6)alkynyl, -(C1-С6)alkyl-N(R24)(С1-С6)alkyl-, -O-(С1-С6)alkyl-, -O(С6-С10)-6-14-element aryl-, N(R24)(С1-С6)alkyl-, optionally substituted 6-14-element aryl or optionally substituted 5-12-element heteroaryl containing 1-3 heteroatoms selected from N, О and S; Z is Н, halogen, -NH2, -CN, -CF3, -(C1-С12)alkyl, -(С2-С12)alkenyl, -(С2-С12)alkynyl, -O-(С1-С12)alkyl or -N(R24)(C1-C12)alkyl; each of R21 and R22 is independently Н or -(С1-С6)alkyl; each R23 is independently Н or -(С1-С6)alkyl; each R24 is independently Н or -(С1-С6)alkyl; each of R25 and R26 is independently Н or optionally substituted -(C1-С6)alkyl; each R27 is independently halogen, -(С1-С6)alkyl or -(C1-С6)heteroalkyl; each R28 is independently halogen, -(С1-С6)alkyl or -(C1-С6)heteroalkyl; R29 is -CH2C(O)NH2 or optionally substituted 6-14-element aryl; R30 is R32 is Н or -(С1-С6)alkyl; R33 is -CH2CN, -ОС(O)(С1-С6)alkyl or -SO2NH2; R34 is -ОН, -NH2, -CN, -CH2CH2CN, -O(С1-С6)alkyl, -C(O)(C1-С6)alkyl, -SO2NH2, etc., where in each case, optional substituents are selected from a group consisting of (С1-С12)alkyl and halogen; р is equal to 0 and q is equal to 0. The invention also relates to specific compounds, a pharmaceutical composition, and a method for the treatment of a bacterial infection.
EFFECT: obtaining compounds for the treatment of bacterial infections.
19 cl, 3 tbl, 58 ex
Title | Year | Author | Number |
---|---|---|---|
MACROCYCLIC ANTIBIOTICS OF WIDE RANGE OF ACTIONS | 2016 |
|
RU2766543C2 |
MACROCYCLIC WIDE-RANGE ANTIBIOTICS | 2018 |
|
RU2779477C2 |
GUANIDINEALKYL-1,1-BIS- PHOSPHONIC ACID DERIVATIVES, AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2114855C1 |
DERIVATIVES OF TETRAHYDROISOQUINOLINE, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR INHIBITION OF SYNAPTIC UPTAKE OF DOPAMINE AND TREATMENT METHOD | 2000 |
|
RU2293728C2 |
MEK INHIBITORS AND THEIR THERAPEUTIC USE | 2021 |
|
RU2812929C1 |
BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773346C2 |
β-D-2ʹ-DEOXY-2ʹ-α-FLUORO-2ʹ-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR TREATMENT OF DISEASES CAUSED BY HCV | 2016 |
|
RU2764767C2 |
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
5-AMINO-4,6-DISUBSTITUTED INDOLE AND 5-AMINO-4,6-DISUBSTITUTED INDOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS | 2008 |
|
RU2483060C2 |
BENZAZEPINE COMPOUNDS, CONJUGATES AND THEIR USE | 2018 |
|
RU2780334C2 |
Authors
Dates
2021-12-08—Published
2016-11-21—Filed